Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating testosterone replacement therapy as an adjunctive ERAS strategy in male patients with end-stage renal disease undergoing kid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Hypogonadism, Male, End Stage Renal Disease (ESRD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING